Enavatuzumab
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Diptanshu Das (talk | contribs) at 13:24, 29 May 2017 (→References: Used dynamic column width using AWB). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 13:24, 29 May 2017 by Diptanshu Das (talk | contribs) (→References: Used dynamic column width using AWB)
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Humanized (from mouse) |
Target | TWEAK receptor |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
KEGG | |
Chemical and physical data | |
Formula | C6334H9792N1700O2000S42 |
Molar mass | 143.1 kg/mol g·mol−1 |
NY (what is this?) (verify) |
Enavatuzumab is a humanized monoclonal antibody used in the treatment of solid tumors.
Enavatuzumab was developed by Facet Biotech Corp.[1]
References
Chemokine |
| ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CSF |
| ||||||||||||
Interferon |
| ||||||||||||
Interleukin |
| ||||||||||||
TGFβ |
| ||||||||||||
TNF |
| ||||||||||||
Others |
|
This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it. |
This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
Hidden categories:
- Articles with changed CASNo identifier
- Chemicals that do not have a ChemSpider ID assigned
- Chem-molar-mass both hardcoded and calculated
- Infobox-drug molecular-weight unexpected-character
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without InChI source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Drugs that are a monoclonal antibody
- All stub articles